We are live on ! Find out more
SWA

Sightline Wealth Advisors Portfolio holdings

AUM $273M
1-Year Est. Return 18.08%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+18.08%
3 Year Est. Return
+44.4%
5 Year Est. Return
+39.28%
10 Year Est. Return
AUM
$101M
AUM Growth
+$2.71M
Cap. Flow
+$2.72M
Cap. Flow %
2.7%
Top 10 Hldgs %
65.52%
Holding
64
New
9
Increased
22
Reduced
3
Closed
2

Sector Composition

Rank Sector Weight
1 Real Estate 1.6%
2 Technology 1.41%
3 Consumer Discretionary 1.1%
4 Consumer Staples 0.63%
5 Healthcare 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
51
Citigroup
C
$222B
$216K 0.21%
4,606
VBK icon
52
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$212K 0.21%
978
AOA icon
53
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.16B
$204K 0.2%
+3,207
New +$206K
NUV icon
54
Nuveen Municipal Value Fund
NUV
$1.91B
$152K 0.15%
17,197
NIM icon
55
Nuveen Select Maturities Municipal Fund
NIM
$117M
$118K 0.12%
12,755
MHI
56
DELISTED
Pioneer Municipal High Income Fund
MHI
$96.1K 0.1%
10,811
STAA icon
57
STAAR Surgical
STAA
$1.16B
-3,250
Closed -$208K

Similar funds

Sightline Wealth Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Sightline Wealth Advisors held 64 positions worth $101M, up 2.8% from $97.9M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sightline Wealth Advisors's Q2 2023 filing shows 9 new, 22 increased, 3 reduced and 2 closed positions. Its largest new stake was WisdomTree Emerging Markets ex-State-Owned Enterprises Fund: 34,540 shares worth $962K. The largest sale was STAAR Surgical, an estimated $208K.

By sector, the portfolio is most concentrated in Real Estate at 1.6% of assets, down from 1.6% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Sightline Wealth Advisors's largest Q2 2023 buy was WisdomTree Emerging Markets ex-State-Owned Enterprises Fund: 34,540 shares worth $962K.
  • Sightline Wealth Advisors added most to Invesco S&P 500 Equal Weight ETF in Q2 2023, an estimated $651K increase.
  • Sightline Wealth Advisors's biggest Q2 2023 reduction was Pfizer, cutting an estimated $80.5K.
  • Sightline Wealth Advisors fully exited STAAR Surgical in Q2 2023, selling an estimated $208K.
  • Sightline Wealth Advisors's ten largest holdings make up 66% of its $101M portfolio in Q2 2023.
  • Sightline Wealth Advisors opened 9 new positions and closed 2 in Q2 2023.
  • Sightline Wealth Advisors's portfolio value rose 2.8% quarter-over-quarter to $101M.

Based on Sightline Wealth Advisors's 13F filing for Q2 2023, filed 14 Jul 2023.